Islet-Cell Mass Preservation and Regeneration in Diabetes Mellitus: Four Factors with Potential Therapeutic Interest
Open Access
- 1 January 2012
- journal article
- review article
- Published by Hindawi Limited in Journal of Transplantation
- Vol. 2012, 1-9
- https://doi.org/10.1155/2012/230870
Abstract
Isletβ-cell replacement and regeneration are two promising approaches for the treatment of Type 1 Diabetes Mellitus. Indeed, the success of islet transplantation in normalizing blood glucose in diabetic patients has provided the proof of principle that cell replacement can be employed as a safe and efficacious treatment. Nonetheless, shortage of organ donors has hampered expansion of this approach. Alternative sources of insulin-producing cells are mandatory to fill this gap. Although great advances have been achieved in generating surrogateβ-cells from stem cells, current protocols have yet to produce functionally mature insulin-secreting cells. Recently, the concept of islet regeneration in which newβ-cells are formed from either residualβ-cell proliferation or transdifferentiation of other endocrine islet cells has gained much interest as an attractive therapeutic alternative to restoreβ-cell mass. Complementary approaches to cell replacement and regeneration could aim at enhancingβ-cell survival and function. Herein, we discuss the value of Hepatocyte Growth Factor (HGF), Glucose-Dependent Insulinotropic Peptide (GIP), Paired box gene 4 (Pax4) and Liver Receptor Homolog-1 (LRH-1) as key players forβ-cell replacement and regeneration therapies. These factors conveyβ-cell protection and enhanced function as well as facilitating proliferation and transdifferentiation of other pancreatic cell types toβ-cells, under stressful conditions.Keywords
Funding Information
- Consejería de Salud Junta de Andalucía (0727/2010)
This publication has 64 references indexed in Scilit:
- Insulin-producing Surrogate β-cells From Embryonic Stem Cells: Are We There Yet?Molecular Therapy, 2011
- Nuclear receptor liver receptor homologue 1 (LRH-1) regulates pancreatic cancer cell growth and proliferationProceedings of the National Academy of Sciences of the United States of America, 2011
- A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effectsNature, 2011
- α Cell–Specific Men1 Ablation Triggers the Transdifferentiation of Glucagon-Expressing Cells and Insulinoma DevelopmentGastroenterology, 2010
- Conversion of adult pancreatic α-cells to β-cells after extreme β-cell lossNature, 2010
- The Ectopic Expression of Pax4 in the Mouse Pancreas Converts Progenitor Cells into α and Subsequently β CellsCell, 2009
- Acute Antibody-Mediated Complement Activation Mediates Lysis of Pancreatic Islets Cells and May Cause Tissue Loss in Clinical Islet TransplantationTransplantation, 2008
- Glucose-Dependent Insulinotropic Polypeptide-Mediated Up-Regulation of β-Cell Antiapoptotic Bcl-2 Gene Expression Is Coordinated by Cyclic AMP (cAMP) Response Element Binding Protein (CREB) and cAMP-Responsive CREB Coactivator 2Molecular and Cellular Biology, 2008
- Liver Receptor Homolog 1 Is a Negative Regulator of the Hepatic Acute-Phase ResponseMolecular and Cellular Biology, 2006
- The Pax4 gene is essential for differentiation of insulin-producing β cells in the mammalian pancreasNature, 1997